Journal
FRONTIERS IN BIOSCIENCE-LANDMARK
Volume 13, Issue -, Pages 2266-2274Publisher
FRONTIERS IN BIOSCIENCE INC
DOI: 10.2741/2840
Keywords
CD4(+); CD25(+); Foxp3(+); T cells; type 1; regulatory T cells; Tregs; Tr1 cells; review
Categories
Ask authors/readers for more resources
Regulatory T cells ( Tregs) having CD4(+) CD25(+) Foxp3(+) or CD4(+) IL-10(+) (Tr1) phenotype and capable of inducing anergy towards self- and alloantigens play an important role in autoimmunity, as well as in tolerance of allografts, pregnancy and cancer. Both thymus-derived T CD4(+) CD25(+) Foxp3(+) natural cells and peripherally-induced T CD4(+) CD25(+) Foxp3(+) cells prevent migration of effector immunocytes to target organs and inhibit their cooperation with antigen-presenting cells. The suppressive function of CD4(+) CD25(+) Foxp3(+) Tregs depends on interactions between stimulatory ( IL-2, CTLA-4) and inhibitory ( GITR, CD28) signals, on stimulation of indoleamine 2,3-dioxygenase (IDO) activity in dendritic cells via CD80/CD86 molecules, and finally on cell-cell inhibition of effector cells by membrane-bound TGF-beta. Anergy of effector cells caused by Tregs could provoke them to secretion of IL-10/TGF-beta in mechanism of bystander suppression. Tr1 cells constitute the distinctive Tregs population which originates from IL-10-primed nave T cells or from T cells induced by tolerogenic IL-10/TGF-beta-expressing dendritic cells. The suppressive activity of Tr1 cells is based on local IL-10/TGF-beta secretion in the peripheral tissues. Tregs have a privileged place in the net of immunological interactions which makes them a possible common target for therapeutic interventions in different diseases.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available